Quality of End-of-Life Care for Children With Cancer
Children's Oncology Group · NCT07412002
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 2425
- US sites recruiting
- 28
- Study start
- July 31, 2026
- Record last updated
- September 4, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study examines the role of access to care, patient/family interactions with the healthcare system, and stress in explaining variations in quality of end-of-life care. The data collected from this study may help researchers develop a model for identifying patients at risk of low-quality end-of-life care as well as recommendations for potential future interventions.
Being studied: Non-Interventional Study
Conditions: Childhood Hematopoietic and Lymphatic System Neoplasm; Childhood Malignant Solid Neoplasm
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Index Child (COG Registered Patient):
- Must be deceased
- \< 18 years old at time of death
- Diagnosed with any oncologic condition
- History of enrollment on Stratum 1 of APEC14B1, Project:EveryChild
- Note: history of treatment on a COG therapeutic trial is not required
- Resided in the United States, including Puerto Rico, as evidenced by most recent address, at the time of death
Bereaved Parent(s):
- Must be a parent, legal guardian, or caregiver (biological or non-biological) of an eligible Index Child enrolled on APEC14B1 with current Consent to Future Contact (e.g., from the APEC14B1 Part B Consent)
- Self-reported confirmation of familiarity with the care received by the Index Child in the last month of their life
- Bereaved parent must understand English or Spanish (written and/or spoken)
- Must be a parent/guardian/key contact from the Index Child's APEC14B1 Future Contact study record or must be referred by one of the APEC14B1 contacts
- Bereaved parent must be >= 18 years old at the time of ALTE24C1 study enrollment
Regulatory Requirements
- Bereaved parent must provide verbal or implied informed consent
- For all participants, all institutional, FDA, and NCI requirements for human studies must be met
Recruiting US locations
Children's Hospital of Alabama
Birmingham, AL 35233
Site contact: Site Public Contact · 205-638-9285 · oncologyresearch@peds.uab.edu
Arkansas Children's Hospital
Little Rock, AR 72202-3591
Site contact: Site Public Contact · 501-364-7373
Kaiser Permanente-Oakland
Oakland, CA 94611
Site contact: Site Public Contact · 877-642-4691 · Kpoct@kp.org
Alfred I duPont Hospital for Children
Wilmington, DE 19803
Site contact: Site Public Contact · 302-651-5572 · Allison.bruce@nemours.org
Golisano Children's Hospital of Southwest Florida
Fort Myers, FL 33908
Site contact: Site Public Contact · 239-343-5333 · molly.arnstrom@leehealth.org
Memorial Regional Hospital/Joe DiMaggio Children's Hospital
Hollywood, FL 33021
Site contact: Site Public Contact · 954-265-1847 · OHR@mhs.net
Nemours Children's Clinic-Jacksonville
Jacksonville, FL 32207
Site contact: Site Public Contact · 302-651-5572 · Allison.bruce@nemours.org
Nemours Children's Hospital
Orlando, FL 32827
Site contact: Site Public Contact · 302-651-5572 · Allison.bruce@nemours.org
Nemours Children's Clinic - Pensacola
Pensacola, FL 32504
Site contact: Site Public Contact · helpdesk@childrensoncologygroup.org
Children's Healthcare of Atlanta - Arthur M Blank Hospital
Atlanta, GA 30329
Site contact: Site Public Contact · 404-785-0232 · Olivia.Floyd@choa.org
Augusta University Medical Center
Augusta, GA 30912
Site contact: Site Public Contact · 706-721-2388 · ga_cares@augusta.edu
Blank Children's Hospital
Des Moines, IA 50309
Site contact: Site Public Contact · 515-241-8912 · samantha.mallory@unitypoint.org
Sinai Hospital of Baltimore
Baltimore, MD 21215
Site contact: Site Public Contact · 410-601-9083
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
Grand Rapids, MI 49503
Site contact: Site Public Contact · 616-391-1230 · crcwm-regulatory@crcwm.org
Bronson Methodist Hospital
Kalamazoo, MI 49007
Site contact: Site Public Contact · 616-391-1230 · crcwm-regulatory@crcwm.org
Children's Mercy Hospitals and Clinics
Kansas City, MO 64108
Site contact: Site Public Contact · 816-302-6808 · COGResearchGroup@cmh.edu
Renown Regional Medical Center
Reno, NV 89502
Site contact: Site Public Contact · 775-982-5050 · Renown-CRD@renown.org
Albany Medical Center
Albany, NY 12208
Site contact: Site Public Contact · 518-262-5513
State University of New York Upstate Medical University
Syracuse, NY 13210
Site contact: Site Public Contact · 315-464-5476
Montefiore Medical Center - Moses Campus
The Bronx, NY 10467
Site contact: Site Public Contact · 718-379-6866 · eskwak@montefiore.org
Rainbow Babies and Childrens Hospital
Cleveland, OH 44106
Site contact: Site Public Contact · 216-844-5437
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, PA 15224
Site contact: Site Public Contact · 412-692-8570 · jean.tersak@chp.edu
Rhode Island Hospital
Providence, RI 02903
Site contact: Site Public Contact · 401-444-1488
Dell Children's Medical Center of Central Texas
Austin, TX 78723
Site contact: Site Public Contact · 512-628-1902 · TXAUS-DL-SFCHemonc.research@ascension.org
UT Southwestern/Simmons Cancer Center-Dallas
Dallas, TX 75390
Site contact: Site Public Contact · 214-648-7097 · canceranswerline@UTSouthwestern.edu
University of Virginia Cancer Center
Charlottesville, VA 22908
Site contact: Site Public Contact · 434-243-6303 · uvacancertrials@hscmail.mcc.virginia.edu
Providence Sacred Heart Medical Center and Children's Hospital
Spokane, WA 99204
Site contact: Site Public Contact · 800-228-6618 · HopeBeginsHere@providence.org
Saint Vincent Hospital Cancer Center Green Bay
Green Bay, WI 54301
Site contact: Site Public Contact · 920-433-8889 · WI_research_admin@hshs.org
Similar studies in Alabama
All healthy volunteers studies in Alabama →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Gadsden, AL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)
Merck Sharp & Dohme LLC
- Location
- Anniston, AL
- Eligibility basics
- Ages 18–65